Diagnosis and treatment for non-dilated pancreaticobiliary maljunction were examined.
Of 65 patients with pancreaticobiliary maljunction,8 patients exhibited non-dilated pancreaticobiliary maljunction in which the maximum diameter of the bile duct in cholangiography was 10 mm or smaller and subjected to further examination.
The subjects consisted of one male and seven female with a mean age of 52 years.
Seven patients complained of abdominal pain, but one had no symptoms. Before operation, all patients were diagnosed as pancreaticobiliary maljunction by ERCP. The confluence type of the pancreatic and biliary ducts was II a in 6 patients and III c1 in 2 patients according to the new Komi′s classification.
Complication in the gallbladder was observed in 7 of the 8 patients, and consisted of gallbladder cancer in 3 patients, cholecystolithiasis in one patient, adenomyomatosis in one patient, cholesterosis in one patient, and polyp in one patient.
Resection of the extrahepatic bile duct and reconstruction of the biliary duct were performed in 4 patients, pancreatoduodenectomy in one patient, chelecystectomy with lymphadenectomy in one patient, cholecystectomy, partial hepatectomy with lymphadenectomy and partial resection of transverse colon and duodenum in one patient, and no resection in one patient. Proliferating cell nuclear antigen labelling index (PCNA L. I. ) was 13.8% in the gallbladder and 5.9% in the bile duct of patients with pancreaticobiliary maljunction. Those values were higher than those of patients without pancreaticobiliary maljuntion. Thus, most patients with non-dilated pancreaticobiliary maljunction have complicated lesions in the gallbladder, which may facilitate diagnosis.
For their treatment an operation for extrahepatic bile duct resection and biliary reconstruction is required since PCNA L. I. is increase in the gallbladder and bile duct.
View full abstract